Target intelligence / Profile preview

Immunoglobulin lambda constant 3 (IGLC3)

Target
IGLC3
Molecular classification
Immunoglobulin, Other
01

Overview

Immunoglobulin lambda constant 3 (IGLC3) encodes the constant region of the lambda light chain in human immunoglobulins (antibodies)[2][7]. Immunoglobulins are membrane-bound or secreted glycoproteins produced by B lymphocytes, and they mediate the humoral immune response by binding antigens, leading to elimination of pathogens. IGLC3 is predicted to enable antigen binding and participate in immunoglobulin-mediated immune responses[1][2][7]. The gene is expressed across various tissues and is a component of blood microparticles and extracellular exosomes[1][6]. IGLC3 is not itself a direct therapeutic target, receptor, or enzyme, but rather a structural part of antibodies, which are commonly exploited in therapy as whole molecules rather than as isolated constant regions[1][2][7].

Other names
immunoglobulin lambda constant 3 (Kern-Oz+ marker)IGLCC3 segmentIg lambda chain C region DOTIg lambda chain C region NEWMIg lambda-3 chain C regionIg lambda-3 chain C regionsimmunoglobulin lambda constant region 3 (Kern-Oz+ marker)
02

Biological functions

Antigen bindingImmune response
03

Disease associations

Other (associated gene-disease term: Autism Spectrum Disorder)

Beyond the preview

Go deeper on Immunoglobulin lambda constant 3 (IGLC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda constant 3 (IGLC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call